ArticleNanomaterials (Basel, Switzerland)2026
Modeling Release Scaffolds for Spinal Cord Tissue Regeneration After Injury Using COMSOL Simulation.
Article in Nanomaterials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The current study illustrates the modeling of a biocompatible poly γ-glutamic acid (PGA)-chitosan-rGO nanocomposite hydrogel scaffold, which showed a promising novel scaffold for stimulating central nerve regeneration that addresses the shortcomings of recent therapies and improves tissue engineering, controls inflammation, and restores lost functions after spinal cord injuries (SCIs). In the implementation part of the study, the COMSOL program's top-notch modeling of a detailed investigation of how a scaffold's in vivo diffusion affects injured neurons. Michaelis-Menten kinetics is used to characterize the enzyme process of releasing the outer covering shell of the scaffold, PGA, from a biomaterial matrix to the nerve cell. Results suggested that the injectable hydrogel scaffold theoretically reduces extracellular glutamate concentrations, presenting a potential mechanism to mitigate localized excitotoxicity. Future in vivo experimental validation is required to determine if this reduction prevents neural cell death.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.